Jeffrey Bluestone
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS) (NCT05027815) | Jeffrey Bluestone | 2021-09-23 |
Track Jeffrey Bluestone automatically
Every clearance here is in the API, with alerts when new ones post.